The modern discovery of "mad ...
The modern discovery of "mad cow disease" in the US has sparked a call for tighter bridles on the use of bovine-derived substances in pharmaceuticals and biologics. At the same time, fears about the spread of genetically engineered (GE) plants and animals have alerted a review of regulations governing GE organisms used to cause pharmaceuticals. These developments may further complicate biotech manufacturing processe further ultimately increase confidence in result quality. EXAMINING GE RISKS With "bio-pharming" upon the rise throughout the US and the
|